1. Home
  2. BLRX vs MESA Comparison

BLRX vs MESA Comparison

Compare BLRX & MESA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLRX
  • MESA
  • Stock Information
  • Founded
  • BLRX 2003
  • MESA 1982
  • Country
  • BLRX Israel
  • MESA United States
  • Employees
  • BLRX N/A
  • MESA N/A
  • Industry
  • BLRX Biotechnology: Pharmaceutical Preparations
  • MESA Air Freight/Delivery Services
  • Sector
  • BLRX Health Care
  • MESA Consumer Discretionary
  • Exchange
  • BLRX Nasdaq
  • MESA Nasdaq
  • Market Cap
  • BLRX 15.3M
  • MESA 42.2M
  • IPO Year
  • BLRX 2011
  • MESA 2018
  • Fundamental
  • Price
  • BLRX $4.49
  • MESA $0.93
  • Analyst Decision
  • BLRX Strong Buy
  • MESA
  • Analyst Count
  • BLRX 2
  • MESA 0
  • Target Price
  • BLRX $19.00
  • MESA N/A
  • AVG Volume (30 Days)
  • BLRX 190.6K
  • MESA 124.7K
  • Earning Date
  • BLRX 08-14-2025
  • MESA 08-15-2025
  • Dividend Yield
  • BLRX N/A
  • MESA N/A
  • EPS Growth
  • BLRX N/A
  • MESA N/A
  • EPS
  • BLRX N/A
  • MESA N/A
  • Revenue
  • BLRX $22,340,000.00
  • MESA $424,030,000.00
  • Revenue This Year
  • BLRX N/A
  • MESA $39.81
  • Revenue Next Year
  • BLRX N/A
  • MESA N/A
  • P/E Ratio
  • BLRX N/A
  • MESA N/A
  • Revenue Growth
  • BLRX 91.68
  • MESA N/A
  • 52 Week Low
  • BLRX $2.30
  • MESA $0.68
  • 52 Week High
  • BLRX $35.60
  • MESA $1.89
  • Technical
  • Relative Strength Index (RSI)
  • BLRX 51.09
  • MESA 41.50
  • Support Level
  • BLRX $4.35
  • MESA $0.91
  • Resistance Level
  • BLRX $4.64
  • MESA $0.97
  • Average True Range (ATR)
  • BLRX 0.40
  • MESA 0.04
  • MACD
  • BLRX -0.07
  • MESA -0.00
  • Stochastic Oscillator
  • BLRX 47.30
  • MESA 27.27

About BLRX BioLineRx Ltd.

BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has an off-strategy, legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.

About MESA Mesa Air Group Inc.

Mesa Air Group Inc is a regional air carrier providing scheduled passenger service. It provides services to the District of Columbia, Canada, Cuba, and Mexico, and cargo services out of Cincinnati/Northern Kentucky International Airport. Flights are operated as American Eagle, United Express, or DHL Express flights to the terms of capacity purchase agreements with American and United and a flight services agreement with DHL. The business has a presence in domestic hubs and cities, including Dallas, Houston, Phoenix, and Washington-Dulles, and other regions.

Share on Social Networks: